Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STING1 | Q86WV6 | 16/20 | 0.89 |
| ▸ | LMNA | P02545 | 2/20 | 0.75 |
| ▸ | RAPGEF3 | O95398 | 2/20 | 0.75 |
| ▸ | GMNN | O75496 | 1/20 | 0.75 |
| ▸ | BLM | P54132 | 1/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.75 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.75 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.75 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22901660 | 1.00 | STING1 (0.89) | STING1LMNARAPGEF3GMNNBLM | |
| SCHEMBL22930771 | 1.00 | STING1 (0.89) | STING1LMNARAPGEF3GMNNBLM | |
| SCHEMBL22901661 | 1.00 | STING1 (0.89) | STING1LMNARAPGEF3GMNNBLM | |
| SCHEMBL21118752 | 1.00 | STING1 (0.89) | STING1LMNARAPGEF3GMNNBLM | |
| SCHEMBL23895049 | 1.00 | STING1 (0.89) | STING1LMNARAPGEF3GMNNBLM | |
| SCHEMBL23635844 | 1.00 | STING1 (0.89) | STING1LMNARAPGEF3GMNNBLM | |
| SCHEMBL24722613 | 1.00 | STING1 (0.89) | STING1LMNARAPGEF3GMNNBLM | |
| SCHEMBL25098577 | 1.00 | STING1 (0.89) | STING1LMNARAPGEF3GMNNBLM | |
| SCHEMBL20822086 | 1.00 | STING1 (0.89) | STING1LMNARAPGEF3GMNNBLM | |
| SCHEMBL21886761 | 1.00 | STING1 (0.89) | STING1LMNARAPGEF3GMNNBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023004440-A2 | STING AGONIST COMBINATION TREATMENTS WITH CYTOKINES | IMMUNESENSOR THERAPEUTICS, INC. (US) | 2023-01-26 | — | — | WO | disclosed |
| WO-2021016204-A1 | ANTIBODY-STING AGONIST CONJUGATES AND THEIR USE IN IMMUNOTHERAPY | IMMUNESENSOR THERAPEUTICS, INC. (US) | 2021-01-28 | — | — | WO | disclosed |